A miscarriage is more than a physical loss. It can leave couples with unanswered questions, emotional distress, and uncertainty about the future, especially when pregnancy loss happens more than once.
Many people ask themselves, "Why do I keep miscarrying?" or "Will I ever have a successful pregnancy?" These are common concerns after recurrent miscarriage.
Although repeated miscarriages can be emotionally and physically overwhelming, advances in reproductive medicine now allow fertility specialists to identify many underlying causes and recommend treatments that may improve the chances of a healthy pregnancy. One such option for selected patients is In Vitro Fertilisation (IVF) with Preimplantation Genetic Testing for Aneuploidy (PGT-A).
According to the American Society for Reproductive Medicine (ASRM), recurrent pregnancy loss affects approximately 2% of women. While it is relatively uncommon, it should always be thoroughly evaluated by a fertility specialist.
Let's explore what recurrent miscarriage is, what causes it, and how IVF with PGT-A may help certain couples achieve a successful pregnancy.
Recurrent miscarriage, also known as recurrent pregnancy loss, refers to experiencing two or more consecutive pregnancy losses. A miscarriage occurs when a pregnancy ends before the 20th week.
If you have experienced multiple miscarriages, your fertility specialist may recommend a comprehensive evaluation to determine whether medical, genetic, or anatomical factors are contributing to the pregnancy losses.
While a single miscarriage is relatively common and does not necessarily increase the risk of another miscarriage, repeated pregnancy loss requires medical investigation.
Recurrent miscarriage can result from one or several contributing factors. In some cases, no clear cause is identified despite thorough testing.
The most common cause of recurrent miscarriage is an abnormal number of chromosomes within the embryo.
Chromosomes contain the baby's genetic material. When an embryo has too many or too few chromosomes, normal development often cannot continue, leading to miscarriage.
These chromosomal abnormalities usually occur during egg or sperm formation and become more common with increasing maternal age.
Structural abnormalities of the uterus may interfere with embryo implantation or pregnancy development.
Examples include:
Certain hormonal and medical conditions may increase miscarriage risk if left untreated.
Autoimmune conditions such as antiphospholipid syndrome and certain blood clotting disorders can reduce blood flow to the developing pregnancy, increasing the risk of miscarriage.
Several lifestyle factors may also contribute to pregnancy loss, including:
Even after comprehensive investigations, some couples receive a diagnosis of unexplained recurrent miscarriage, where no definite cause can be identified.
Your fertility specialist may recommend a detailed medical evaluation to identify any treatable causes before planning another pregnancy.
Investigations may include:
These tests help identify conditions that may contribute to pregnancy loss and guide the most appropriate treatment plan.
In Vitro Fertilisation (IVF) involves collecting eggs from the ovaries and fertilising them with sperm in a specialised laboratory. The resulting embryos are cultured before transfer into the uterus.
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is an advanced laboratory technique performed during IVF.
During PGT-A:
This process helps fertility specialists identify embryos with the greatest likelihood of resulting in a healthy pregnancy.
For some couples, IVF combined with PGT-A may reduce the risk of miscarriage caused by chromosomal abnormalities.
It is important to understand that PGT-A does not treat miscarriage itself. Instead, it helps identify embryos that are less likely to carry chromosome abnormalities.
Embryos with the correct number of chromosomes have a higher chance of successful implantation and continued development.
When recurrent miscarriage is caused by embryo chromosome abnormalities (aneuploidy), PGT-A may reduce the likelihood of transferring affected embryos.
PGT-A provides valuable genetic information that helps fertility specialists make informed decisions regarding embryo selection and transfer.
However, not every miscarriage is caused by chromosomal abnormalities. If another medical condition is responsible, additional treatment may be required.
IVF with PGT-A is not suitable for every patient with recurrent miscarriage.
Your fertility specialist will evaluate several factors before recommending this treatment.
A personalised fertility assessment is essential to determine whether IVF with PGT-A is likely to improve your chances of a successful pregnancy.
At MMCIVF Dubai, couples experiencing recurrent miscarriage receive a comprehensive fertility evaluation before beginning treatment to identify any underlying causes.
The fertility specialists use advanced diagnostic testing, modern reproductive technologies, and evidence-based treatment protocols to develop an individualised care plan for every patient.
For suitable candidates, advanced treatments such as IVF with PGT-A may be recommended to improve embryo selection and increase the chances of a healthy pregnancy.
Whether you are planning another pregnancy or considering fertility treatment, MMCIVF provides compassionate support, personalised care, and expert guidance throughout your fertility journey.
Experiencing recurrent miscarriage can be emotionally challenging, but it does not mean that a healthy pregnancy is impossible.
Identifying the underlying cause is the first step toward selecting the most appropriate treatment.
For some couples, IVF with PGT-A may help reduce the risk of miscarriage caused by chromosomal abnormalities by selecting embryos with the correct chromosome number before transfer.
Combined with a comprehensive fertility assessment and personalised medical care, this approach may improve the chances of achieving a healthy pregnancy.
If you have experienced more than one miscarriage, consulting a fertility specialist can help determine the most appropriate investigations and treatment options for your individual situation.
Most fertility specialists define recurrent miscarriage as two or more consecutive pregnancy losses.
No. Many couples experiencing recurrent miscarriage are able to conceive naturally. The focus is on identifying and treating any underlying causes of pregnancy loss.
No. PGT-A cannot prevent every miscarriage. However, it may reduce the risk of miscarriage caused by chromosomal abnormalities by selecting embryos with a normal chromosome count before transfer.
Patients with recurrent miscarriage related to chromosomal abnormalities, advanced maternal age, abnormal genetic testing results, or other clinical indications may benefit from IVF with PGT-A. A fertility specialist can determine whether this treatment is appropriate for your specific circumstances.
Schedule a consultation with our expert team at MMC IVF. We are here to provide personalized care and support.
MMCIVF and Zivanza Wellness are trademarks and tradenames owned by MUrgency Inc., USA.
Services listed on the MMCIVF.com website are available in each Country we provide services in through MMCIVF Affiliated Clinics licensed, regulated and supervised by the Competent Authorities in the respective Country and based on the applicable laws, rules and regulations in the respective Country / Jurisdiction.
MMCIVF operates Clinics in each Country as aforesaid above under the laws, rules and regulations of the respective Country. All patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Clinics and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents are expected to be fully compliant with the laws, rules and regulations in the respective Country and of any other jurisdiction they (the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents) are subject to. MMCIVF Country / MMCIVF Country Directors / MMCIVF Country Doctors / MMCIVF Country Nurses / MMCIVF Country Staff / MMCIVF Country Agents cannot and will not take any responsibility and / or liability for compliance or non-compliance of any law, rule or regulation outside the respective Country where treatment is sought and provided which is solely the responsibility of the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents.
Further, MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents will not solicit and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India to Indian Citizens / Residents (whether in India or outside India) strictly following this as MMCIVF Country policy recognizing and respecting applicable Indian Laws, Rules, and Regulations. All Indian Citizens / Residents are advised to ensure that they fully comply with the applicable Indian Laws, Rules, and Regulations while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. MMCIVF Country shall not take any responsibility whatsoever for any violation of any applicable Indian Laws, Rules, and Regulations by any Indian Citizen / Resident while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country which sole responsibility shall vest with such Indian Citizens / Residents reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. In case any individual / agency / firm / company reaches out to any Indian Citizen / Resident for and on behalf of MMCIVF Country for any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India, please be known that we have not authorized any staff member / individual / agency / firm / company to reach out to Indian Citizens / Residents (whether in India or outside India) to offer and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India. If you are aware of any such reach outs and / communication, please inform MMCIVF Country at info@mmcivf.ae immediately so that we can take remedial measures against such reach outs claiming to represent MMCIVF Country.
Further, MMCIVF in each Country operates independently and separately from other MMCIVF Clinics in Other Countries.
NOTE: Please read Country as respective Country – USA, Kenya, Georgia, Tanzania and United Arab Emirates as appropriate, relevant and applicable.